WebDisclosure WebDisclosure
Basculer en Français
10885 Companies
236936 Keywords
165834 Articles
127157 Press releases
Headlines Articles Press releases Wiremind Remove
  1. Home
  2. Companies
  3. Wiremind
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/04/2025 at 11:10, 9 months 22 days ago

    Basile Bonnier Appointed as Chief Customer Success Officer at Wiremind

    Customer Success Digital Transformation Transport Solutions Wiremind Basile Bonnier
  • BRIEF

    published on 11/04/2025 at 11:10, 9 months 22 days ago

    Basile Bonnier nommé directeur de la réussite client chez Wiremind

    Transformation Numérique Succès Client Solutions De Transport Wiremind Basile Bonnier
  • PRESS RELEASE

    published on 11/04/2025 at 11:05, 9 months 22 days ago

    Basile Bonnier Joins Wiremind as Chief Customer Success Officer

    Basile Bonnier joins Wiremind as Chief Customer Success Officer, leading Customer Success organization for Passenger solutions. Wiremind focuses on customer needs and innovation
    Innovation Wiremind Basile Bonnier Chief Customer Success Officer Passenger Solutions
    Logo of Wiremind
Accesswire
  • Published on 08/27/2026 at 02:00, 10 minutes ago

    Algo Grande Copper Announces Upsizing of Private Placement

  • Published on 08/27/2026 at 00:05, 2 hours 5 minutes ago

    Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)

  • Published on 08/26/2026 at 23:00, 3 hours 10 minutes ago

    Datametrex Announces Transition to Semi-Annual Financial Reporting

  • Published on 08/26/2026 at 22:30, 3 hours 40 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 08/26/2026 at 22:30, 3 hours 40 minutes ago

    Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 23:05, 3 hours 5 minutes ago

    Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

  • Published on 08/26/2026 at 18:44, 7 hours 25 minutes ago

    AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results

  • Published on 08/26/2026 at 18:40, 7 hours 30 minutes ago

    MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM

  • Published on 08/26/2026 at 18:30, 7 hours 40 minutes ago

    Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

  • Published on 08/26/2026 at 18:00, 8 hours 10 minutes ago

    MHM Corporate: reduces the nominal value of its shares to €0.011

View all EQS
Les Echos
  • Published on 08/26/2026 at 18:02, 8 hours 8 minutes ago

    Altareit: Altarea press release regarding the Primonial matter

  • Published on 08/26/2026 at 18:02, 8 hours 8 minutes ago

    Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial

  • Published on 08/26/2026 at 18:00, 8 hours 10 minutes ago

    Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

  • Published on 08/26/2026 at 18:00, 8 hours 10 minutes ago

    Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)

  • Published on 08/26/2026 at 18:00, 8 hours 10 minutes ago

    KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy